Kw-2871

Kw-2871 Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Treatment of malignant melanoma (monoclonal antibody).

Kw-2871 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Kw-2871 Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
NCE Biomedical Co.,Ltd.	4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988		China	1493	55
LETOPHARM LIMITED	+86-21-5821 5861	sales@letopharm.com	China	2384	58
SPIRO PHARMA		eric_feng1954@126.com	China	9248	55
ShangHai Biochempartner Co.,Ltd	17754423994 17754423994	2853530910@QQ.com	China	8011	62
Guangzhou Hongyuan Chemical Co.,Ltd	15817493340	981810490@qq.com	China	1566	58
Wuhan Chemstan Biotechnology Co., Ltd.	027-65317797 15926423062	422450190@qq.com	China	10457	58
Biolab Reagents	027-65279366 18108604862	products@biolabreagent.com	China	9818	58
Wuhan Jingkangen Biomedical Technology Co., Ltd	13720134139 13720134139	orders@jknbiochem.com	China	5839	58
Shanghai Yifei Biotechnology Co. , Ltd.	021-65675885 18964387627	customer_service@efebio.com	China	11974	58
Changsha Fuzhen Biotechnology Co.，LTD	13823398779 18670069958	3062105966@qq.com	China	3343	58

---

• Ecromeximab
• Km871
• Kw 2871
• Kw-2871
• ECROMEXIMABUM
• Research Grade Ecromeximab (DGK11301)
• Research Grade Ecromeximab
• 292819-64-8